Zobrazeno 1 - 10
of 71
pro vyhledávání: '"ROXANA IRINA IANCU"'
Autor:
Camil Ciprian MIRESTEAN, Mihai Cosmin STAN, Roxana Irina IANCU, Dragos Petru Teodor IANCU, Florinel BADULESCU
Publikováno v:
Modern Medicine, Vol 30, Iss 3, Pp 175-180 (2023)
The majority of skin cancers of the head and neck are represented by basal cell carcinoma (BCC) and cutaneous squamosal cell carcinoma (CSCC), both non-melanoma skin cancers. Identified in the early stages, the cure rate is considered high. Sun prote
Externí odkaz:
https://doaj.org/article/19b0340e8fa04b4e88e93c508a0ebe57
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4805-4816 (2023)
Altered fractionation concepts and especially moderate hypo-fractionation are evaluated as alternatives to standard treatment for head and neck squamous cell carcinoma (HNSCC), associated with or not concurrent with or sequential to chemotherapy. The
Externí odkaz:
https://doaj.org/article/a1ea26658cfb4c5bab19e3dafcf14f4a
Autor:
Camil Ciprian MIRESTEAN, Roxana Irina IANCU, Mihai Cosmin STAN, Dragos Petru Teodor IANCU, Florinel BADULESCU
Publikováno v:
Modern Medicine, Vol 30, Iss 1, Pp 23-28 (2023)
Concurrent chemo-radiotherapy with Cisplatin is the standard treatment for locally advanced non-metastatic squamous cell carcinoma of the head and neck (HNSCC), but induction chemotherapy (IC) followed by chemo-irradiation, even controversial is a wi
Externí odkaz:
https://doaj.org/article/316be8a963e24d61bf17636ca9b32f40
Publikováno v:
Modern Medicine, Vol 29, Iss 4, Pp 273-278 (2022)
Although adjuvant radiotherapy in combination with Temozolomide administration has clearly demonstrated the benefit in improving the prognosis of patients with multiforme glioblastoma, radiotherapy as only treatment or in combination with systemic tr
Externí odkaz:
https://doaj.org/article/45f353e383a748fd938195442615df6a
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7388-7395 (2022)
Immunotherapy, the modern oncological treatment with immune checkpoint inhibitors (ICIs), has been part of the clinical practice for malignant melanoma for more than a decade. Anti-cytotoxic T-lymphocyte antigen 4 (CTLA4), anti-programmed cell death
Externí odkaz:
https://doaj.org/article/d59c13da11d34d8dbf5fc196de31d7f2
Publikováno v:
Modern Medicine, Vol 29, Iss 3, Pp 181-185 (2022)
Mutations in the tyrosine kinase (TKD) domain of the epidermal growth factor receptor (EGFR) are involved in the unfavorable therapeutic response through resistance to targeted molecular therapy. Data from the clinical experience of non-small cell lu
Externí odkaz:
https://doaj.org/article/a0380850f8dd42438fa8dad5ab31861e
Autor:
Camil Ciprian Mireștean, Mihai Cosmin Stan, Roxana Irina Iancu, Dragoș Petru Teodor Iancu, Florinel Bădulescu
Publikováno v:
Diagnostics, Vol 13, Iss 22, p 3396 (2023)
Introduction: Neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and pallets-to-lymphocyte ratio (PLR) are currently validated as cheap and accessible biomarkers in different types of solid tumors, including head and neck cance
Externí odkaz:
https://doaj.org/article/664509429c2f4ead89a5eb5d8c3ae3af
Autor:
Camil Ciprian Mireștean, Cristiana Eugenia Simionescu, Roxana Irina Iancu, Mihai Cosmin Stan, Dragoș Petru Teodor Iancu, Florinel Bădulescu
Publikováno v:
Diagnostics, Vol 13, Iss 19, p 3026 (2023)
Chondrosarcoma represents approximately 0.1% of all neoplasms of the head and neck and is considered a rare disease with a relatively good prognosis. The 5-year overall survival (OS) rate is estimated at 70–80%, being considered a disease with a lo
Externí odkaz:
https://doaj.org/article/ec90a62134414a2fa47084ed7604e613
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 816-833 (2022)
Even though it is only the 6th most common malignancy at the modal level, head and neck cancers are distinguished by a considerable treatment failure rate, especially by locoregional recurrences, the intrinsic tumor radioresistance being one of the c
Externí odkaz:
https://doaj.org/article/cc0a785d7e304dbe841ca7e14df65fd2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor radiation resistance along with chemotherapy resistance is one of the main causes of therapeutic failure of radiotherapy-treated head and neck cancers. 100 years after the discovery of the Warburg effect, a process specific to malignant cells t
Externí odkaz:
https://doaj.org/article/ca7e1758ed0044c69ee0b0e15815392a